) Sell and Administration Expenses (29.73) (37.21) (7.48) (20.10) Net Profit (Loss) (32.44) (29.42) 3.02 10.27 Earnings per share (Baht per share) (0.007) (0.007) 0.00 0.00 Net Profit The company and
Expenses 27.46 38.55 (11.09) (28.77) Net Profit (Loss) (41.80) (83.80) 42.00 50.12 Earnings per share (Baht per share) (0.0092) (0.0185) 0.0093 50.27 Net Profit The company and subsidiaries realized net loss
3rd Quarter of 2016. This transaction has the significant impact when comparing the value of sharing of gain from investment value of the associates of the 3rd Quarter of Baht 3.95 million with the
, with 0.18 million baht decrease with no significantly transaction changes. 2. Cost of sale , Profit margin For Quarter 1 of the year 2020, the company had cost of sale of 98.36 million bath compare to
35.06% Gross Profit Margin (%) 12.08% 10.15% 1.93% SG&A expenses 390 389 1 0.15% EBIT before share of profit (loss) from investment in associates and joint venture 438 398 40 10.04% Share of profit (loss
10.5% Gross Profit Margin (%) 11.1% 12.1% -1.0% SG&A expenses 392 390 2 0.6% Loss on exchange rate 4 0 4 N/A EBIT before share of profit (loss) from investment in associates and joint venture 435 438 -3
Margin (%) 12.6% 11.1% 1.5% SG&A expenses 458 392 66 16.8% Loss on exchange rate 35 4 32 904.4% EBIT before share of profit (loss) from investment in associates and joint venture 604 435 169 38.9% Share of
% % Administrative Expenses to Sales** 10.6% 9.6% - 10.6% 8.8% Finance Costs 17 6 +184% 60 22 +171% Share of profit (loss) from investments in JV (0.1) (11) +99% (15) (22) +34% Tax expenses (income) (48) (15) -231
measurements directly affect with the business of Wuttisak Clinic Intergroup Co., Ltd. (“Wuttisak Clinic” or “WCIG” indirect subsidiary, hold share by WCI Holding PCL) to close all branches resulting in lack of
of the previous year, mostly from revenue from Trading (Big Lot – non regular transaction) decreased Baht 852.55 million. 2. Gross profit was Baht 55.63 million which decreased Baht 53.55 million or